Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Nov 16 - Nov 21
Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, Vollenweider P, Lyssenko V, Bouatia-Naji N, Dupuis J, Jackson AU, et al
Tirzepatide is a dual GLP-1 and GIP receptor agonist, often described as a twincretin. It is a single synthetic peptide designed to activate two incretin receptors simultaneously rather than one
If your calculated dose differs from what your provider prescribed, contact them before administering your medication
Common changes: Typical cumulative loss by 2 months: 818 pounds (depending on starting weight and dose) By month three, before-and-after changes are noticeable for many patients
US$ 28.08
US$ 28.08
US$ 27.31
